Word

ARAVALENT

Status

Dead

Status Code

605

Status Date

Monday, April 18, 2022

Serial Number

90716789

Mark Type

4000

Filing Date

Monday, May 17, 2021

Published for Opposition

Tuesday, March 1, 2022

Abandoned Date

Monday, April 18, 2022

Trademark Owner History

Aravalent Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer

42 Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; biological research and analysis; chemical research; medical research, namely, conducting clinical trials for others

Trademark Events

Apr 18, 2022

Abandonment Notice E-Mailed - After Publication

Apr 18, 2022

Abandonment - After Publication

Apr 13, 2022

Teas Express Abandonment Received

Mar 30, 2022

Extension Of Time To Oppose Received

Mar 1, 2022

Official Gazette Publication Confirmation E-Mailed

Mar 1, 2022

Published For Opposition

Feb 9, 2022

Notification Of Notice Of Publication E-Mailed

Jan 26, 2022

Approved For Pub - Principal Register

Jan 25, 2022

Assigned To Examiner

Aug 16, 2021

New Application Office Supplied Data Entered In Tram

May 20, 2021

New Application Entered In Tram